International Perfusion Association

Category: VAD

Heart Failute

Test Bench for Right Ventricular Failure Reversibility: The Hybrid BiVAD Concept

Patients with biventricular cardiogenic shock, ineligible for heart transplantation, may benefit from a micro-invasive hybrid BiVAD approach, combining the ProtekDuo cannula and the Impella 5.5 trans-aortic pump. This strategy, beyond ECMO, allows for physiological circulation, biventricular unloading, and accurate evaluation of right ventricular function, leading to the possibility of transitioning to less invasive, durable left ventricular assist device (LVAD) implantation.

READ MORE

Artificial Intelligence-Based Analysis of Body Composition Predicts Outcome in Patients Receiving Long-Term Mechanical Circulatory Support

This study used artificial intelligence to analyze preoperative CT scans of heart failure patients receiving left ventricular assist device (LVAD) implantations, revealing that greater adipose tissue areas are associated with higher postoperative complications and in-hospital mortality. It concluded that preoperative body composition, particularly adipose tissue, can predict poorer outcomes post-LVAD implantation, impacting postoperative quality of life and walking distance.

READ MORE

Mechanical Circulatory Support in Cardiogenic Shock

The abstract outlines the evolving management of cardiogenic shock, highlighting the transition to using temporary mechanical circulatory support (t-MCS) like IABP, VA-ECMO, Impella, and ECPELLA, informed by advances in circulatory physiology. It emphasizes the importance of selecting appropriate t-MCS devices based on patient-specific conditions, shock stage, and risk, guided by hemodynamic monitoring and a multidisciplinary team approach.

READ MORE

A Multipurpose Extracorporeal Life Support Circuit: A Concept for Multiorgan Transplant and Circulatory Support Service Healthcare Provider

We propose the creation of a multipurpose circuit that integrates multiple extracorporeal life support (ECLS) functions to cater to diverse medical needs. This innovative circuit not only offers cost-effectiveness and enhanced safety but also ensures optimal utilization, thereby revolutionizing the realm of life support technologies.

READ MORE

Clinical Indications and Outcomes of Impella Devices for Severe Cardiogenic Shock in COVID-19 Patients: A Systematic Review

Coronavirus disease 2019 (COVID-19) can present with significant cardiac dysfunction, including cardiogenic shock. Mechanical circulatory support with an Impella device may be utilized in these patients to support and offload native right ventricle (RV) and left ventricle (LV) functions. This systematic review aims to describe clinical indications, management, laboratory data, and outcomes in patients with severe cardiogenic shock from COVID-19 treated with an Impella device.

READ MORE